Lower, more frequent cisplatin dosing minimizes hearing loss in head and neck cancer
降低顺铂给药剂量并增加给药频率可最大程度地减少头颈癌患者的听力损失。
期刊:JCI Insight
影响因子:6.1
doi:10.1172/jci.insight.196230
Fernandez, Katharine A; Chowdhury, Abu S; Bonczkowski, Amanda; Allen, Paul D; Campbell, Maura H; Lee, David S; Malhotra, Charvi; Page, Brandi R; Mulford, Deborah A; Ortiz, Candice Evita; Santa Maria, Peter L; Kullar, Peter; Khan, Saad A; Newlands, Shawn D; Schmitt, Nicole C; Cunningham, Lisa L